Aurobindo Pharma fundamental analysis

AUROPHARMA

1141.7

25.90 (-2.22%)
Last updated on 20 Jan, 2026 | 15:50 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Aurobindo Pharma Fundamentals

P/E Ratio

19.89

P/B Ratio

1.94

Div. Yield

0

Sector P/E

69.39

Sector P/B

0.98

Sec. Div. Yield

0.57

Aurobindo Pharma Fundamentals is currently trading with a P/E Ratio of 19.89, compared to the sector average of 69.39. Its P/B Ratio stands at 1.94, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.

Aurobindo Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Average

On its scorecard, Aurobindo Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.